Monitoring and telematic control of people with kidney transplant and suspected COVID-19 infection
e202103043
Keywords:
COVID-19, Coronavirus, Chronic kidney disease, Kidney transplant, Immunosuppression, TelemedicineAbstract
Background: People with Kidney Transplantation require immunosuppressant treatments and this classifies them as a population at risk for virus and/or bacterial infections. The objective of the study was to describe the follow-up of transplanted people with suspected COVID19 infection.
Methods: Descriptive, cross-sectional, observational study with prospective follow-up carried out between March and June 2020. Sociodemographic and clinical data were recorded for the assessment, control and follow-up of the cases. The results were expressed with means and standard deviation, median and interquartile range, or frequencies and percentages. The chi-square test was used to compare qualitative variables and the Student’s T test to compare quantitative variables with normal distribution. If they did not follow a normal distribution, the Mann Whitney U test was used. The level of statistical significance was established at p<0.05.
Results: A total of 56 patients were included, with a mean of 62.73±13.01 years and a median of 39.5 [7.5; 93] months transplanted. 2.48±2.69 calls/patient were made during a period of 3.46±4.41 days. Virtual follow-up was performed with 100% (n=56) and 71.43% (n=40) required hospital admission at some point. 28.57% (n=16) of the people evaluated were managed at home. The PCR test was performed on 85.71% (n=48) of the study population, being positive in 48.21% (n=27). 29.62% (n=8) of the positive cases required invasive mechanical ventilation and 33.33% (n=9) died. The mortality rate in the study population is 4.17 times higher than that presented in the data from the registries in the general population.
Conclusions: According to the mortality data, it is essential to maintain close contact with the main objective of referring the case to the hospital system at the slightest suspicion of complication. Remote monitoring is offered as a positive opportunity for the control of transplant recipients who require close monitoring by the nursing team.
Downloads
References
Paules CI, Marston HD, Fauci AS. Coronavirus Infections - More Than Just the Common Cold. JAMA. 2020;323(8):707–708.
World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports. [Internet]. Ginebra, Suiza [consultado en mayo 2020]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Hu Y, Sun J, Dai Z, Haohua D, Xin L, Qi H et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020;127:104371.
Red Nacional de Vigilancia Epidemiológica (RENAVE). Informe sobre la situación de COVID-19 en España. Informe COVID-19 nº 33. 29 de mayo de 2020 [Internet]. Madrid, España [consultado en mayo 2020]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20n%C2%BA%2032.%20Situaci%C3%B3n%20de%20COVID-19%20en%20Espa%C3%B1a%20a%2021%20de%20mayo%20de%202020.pdf
Arcos E, Pérez-Sáez MJ, Comas J, Lloveras J, Tort J, Pascual J et al. Assessing the Limits in Kidney Transplantation: Use of Extremely Elderly Donors and Outcomes in Elderly Recipients. Transplantation. 2020;104(1):176-183.
Organización Nacional de Trasplantes. Actividad de donación y trasplante España 2019. [Internet]. Madrid, España [consultado en mayo 2020]. Disponible en: http://www.ont.es/infesp/Memorias/ACTIVIDAD%20DE%20DONACI%C3%93N%20Y%20TRASPLANTE%20ESPA%C3%91A%202019.pdf
Li J, Li SX, Zhao LF, Kong DL, Guo ZY. Management recommendations for patients with chronic kidney disease during the novel coronavirus disease 2019 (COVID-19) epidemic. Chronic Dis Transl Med [Internet]. 2020;10: Online ahead of print.
Bartz CC. Les soins infirmiers en télémédecine et télésanté dans le monde [Nursing care in telemedicine and telehealth across the world]. Soins. 2016;61(810):57-59.
Servei de Nefrologia, Unitat de Trasplantament Renal. Memoria d’activitat de Trasplantament Renal. [Documentación Interna]. Barcelona, España. Solicitar a: mcrespo@psmar.cat
Charlson ME, Pompei P, Ales AL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
López V, Vázquez T, Alonso-Titos J, Cabello M, Alonso A, Beneyto I et al. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients [published online ahead of print, 2020 Apr 3]. Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal [online ahead of print]. Nefrologia. 2020;S0211-6995(20)30037-0.
Boletín Oficial del Estado. Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales. [Internet]. 2018. [consultado en mayo 2020]. Disponible en: https://www.boe.es/eli/es/lo/2018/12/05/3/dof/spa/pdf
European Parliament. Official Journal of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). [Internet]. 2016. [consultado en mayo 2020]. Disponible en: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679&from=EN
The Columbia University Kidney Transplant Program. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. JASN. 2020;31(6):1150-1156.
Parimbelli E, Bottalico B, Losiouk E, Tomasi M, Santosuosso A, Lanzolaet G et al. Trusting telemedicine: A discussion on risks, safety, legal implications and liability of involved stakeholders. Int J Med Inform. 2018;112:90-98.
Hagge D, Knopf A, Hofauer B. Chancen und Einsatzmöglichkeiten von Telemedizin in der Hals , Nasen- und Ohrenheilkunde bei der Bekämpfung von SARS-COV-2: Narratives Review [Telemedicine in the fight against SARS-COV-2-opportunities and possible applications in otorhinolaryngology: Narrative review]. HNO. 2020;68(6):433-439.
Peine A, Paffenholz P, Martin L, Dohmen S, Marx G, Loosen S. Telemedicine in Germany during the COVID-19 Pandemic: Multiprofessional National Survey [published online ahead of print, 2020 Jun 21]. J Med Internet Res. 2020;10.2196/19745
Cormi C, Chrusciel J, Laplanche D, Dramé M, Sanchez S. Telemedicine in nursing homes during the COVID-19 outbreak: A star is born (again). Geriatr Gerontol Int. 2020;20(6):646-647.
Bartiromo M, Borchi B, Botta A, Bagalà A, Lugli G, Tilli M et al. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) [online ahead of print]. Transpl Infect Dis. 2020;10.1111/tid.13286
Li X, Xu S, Yu M, Wang K, Tao Y, Zhouet Y et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. [online ahead of print] J Allergy Clin Immunol. 2020;(20)30495-4.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Penget J et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis [online ahead of print]. J Infect. 2020;S0163-4453(20)30234-6.
Crespo M, Pérez-Sáez MJ, Redondo-Pachón D, Llinàs-Mallol L, Montero MM, Villar-García J et al. COVID-19 in elderly kidney transplant recipients. Am J Transplant. 2020;00:1– 7.
Gilbert AW, Billany JCT, Adam R, Martin L, Tobin R, Bagdai S et al. Rapid implementation of virtual clinics due to COVID-19: report and early evaluation of a quality improvement initiative. BMJ Open Qual. 2020;9(2):e000985.
Lam PW, Sehgal P, Andany N, Mubareka S, Simor AE, Ozaldin O et al. A virtual care program for outpatients diagnosed with COVID-19: a feasibility study. CMAJ Open. 2020;8(2):E40-E413.
O’ Reilly MF, Merghani K, Sheehan E. Virtualised care and COVID-19 [online ahead of print]. Ir J Med Sci. 2020;10.1007/s11845-020-02269-5
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Anna Bach-Pascual, Guillermo Pedreira-Robles, María José Pérez-Sáez, Anna Buxeda-Porras, Carlos Enrique Arias-Cabrales, Marta Crespo-Barrio, Ernestina Junyent-Iglesias, María Dolores Redondo-Pachón
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.